Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion

Chemotherapy

Volumn 45, Issue SUPPL. 1, 1999, Pages 54-66

  Berman, J ^a   Dietze, R ^b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b Walter Reed Army Inst of Research ^*

Author keywords

Amphocil(TM); Kala azar; Leishmaniasis; Treatment

Indexed keywords

AMPHOTERICIN B CHOLESTEROL SULFATE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; FEMALE; FEVER; HUMAN; MALE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS, PHASE II; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; TREATMENT OUTCOME;

EID: 0032988574     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048471     Document Type: Article

References (29)

1. Seaman J, Pryce D, Sondorp HE, Moody A, Bryceson ADM, Davidson RN: Epidemic visceral leishmaniasis in Sudan: A randomised trial of aminosidine plus stibogluconate versus sodium stibogluconate alone. J Infect Dis 1993;168: 715-720.
2. Magill AJ, Grogl M, Gasser RA, Sun W, Oster CN: Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm. New Eng J Med 1993;328:1383-1387.
3. Berenguer J, Moreno S, Cercenado E, de Quiros JCLB, de la Fuente AC, Bouza E: Visceral leishmaniasis in patients infected with human immunodeficiency virus. Ann Int Med 1989;111:129-132.
4. Thakur CP, Kumar K: Post kalaazar dermal leishmaniasis: A neglected aspect of kala-azar control programmes. Ann Trop Med Parasitol 1992;86:355-359.
5. El Hassan AM, Ghalib HW, Zijlstra EE, Eltoum IA, Satti M, Ali MS, Ali HMA: Post kala-azar dermal leishmaniasis in the Sudan: Clinical features, pathology and treatment. Trans Roy Trop Med Hyg 1992;86: 245-248.
6. Ashford RW, Desjeux P, deRaadt P: Estimation of population at risk of infection and number of cases of leishmaniasis. Parasitol Today 1992;8:104-105.
7. Herwaldt BL, Berman JD: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992;46:296-306.
8. Gasser RA, Magill AJ, Oster CN, Franke ED, Grog] M, Berman JD: Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis. Clin Infect Dis 1994;18:83-90.
9. Berman JD: Leishmaniasis chemotherapy: Biochemical mechanisms, clinical efficacy, and future strategies. Rev Infect Dis 1988;10:560-586.
10. Hart DT, Lauwers WJ, Willemsens G, Vanden Bossche H, Opperdoes FR: Perturbation of sterol biosynthesis by itraconazole and ketoconazole in Leishmania mexicana mexicana infected macrophages. Mol Biochem Parasitol 1989;33:123-134.
11. Berman JD, Good LJ, Beach DH, Holz GG: Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine tumor cells. Mol Biochem Parasitol 1986;20:85-92.
12. Berman JD, Wyler DJ: An in vitro model for investigation of chemotherapeutic in Leishmaniasis. J Infect Dis 1980;142:83-86.
13. Prata A: Treatment of kala-azar with amphotericin B. Trans R Soc Trop Med Hyg 1963;57:266-268.
14. Sampaio SAP, Godoy JT, Paiva L, Dillon NL, Lacaz CS. The treatment of American mucocutaneous leishmaniasis with amphotericin B: Report of 70 cases. Arch Dermatol 1960;82:627-635.
15. Mishra M, Singh MP, Choudhury D, Singh VP, Khan AB: Amphotericin B for second-line treatment of Indian kala-azar. Lancet 1991;337: 926.
16. Mishra M, Biswas UK, Jha DN, Khan AB: Amphotericin versus pentamidine in antimony-unresponsive kala-azar. Lancet 1992;340:1256-1257.
17. Mishra M, Biswas UK, Jha AM, Khan AB: Amphotericin versus sodium stibogluconate in first-line treatment of Indian kala-azar. Lancet 1994;244:1599-1600.
18. Thakur CP, Sinha GP, Pandey AK, Barat D, Sinha PK: Amphotericin B in resistant kala-azar in Bihur. Nat Med J India 1993;6:57-60.
19. Thakur CP, Sinha GP, Sharma V, Pandey AK, Kumar M, Verma BB: Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar. Indian J Med Res[A] 1993;97:170-175.
20. Berman JD, Ksionski G, Chapman WL, Waits VB, Hanson WL: Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrob Agents Chemother 1992;36:1978-1980.
21. Davidson RN, Croft SL, Scott A, Maini M, Moody AH, Bryceson AD: Liposomal amphotericin B in drug-resistant visceral leishmaniasis. Lancet 1991;337:1061-1062.
22. Davidson RN, Martino LD, Gradoni L, Ciacchino R, Russo R, Gaeta GB, Pempinello R, Scott S, Raimondi F, Cascio A, Prestileo T, Caldeira L, Wilkinson RJ, Bryceson ADM: Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: A multi centre trial. Quart J Med 1994;87:75-81.
23. Giacchino R, Giambartolomei G, Tasso L, Timitill A, Castagnola E, Brisigotti M, Micalizzi C: Treatment with liposomal amphotericin B of a child affected with drug-resistant visceral leishmaniasis. Trans R Soc Trop Med Hyg 1993;87:310.
24. Torre-Cisneros J, Villanueva JL, Kindelan JM, Jurado R, Sanchez-Guijo P: Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with HIV. Clin Infect Dis 1993;17:625-627.
25. Davidson RN, Russo R: Relapse of visceral leishmaniasis in patients who were coinfected with HIV and who received treatment with liposomal amphotericin B. Clin Infect Dis 1994;19:560.
26. McBride M, Linney M, Claydon EJ, Weber J: Visceral leishmaniasis following treatment with liposornal amphotericin B. Clin Infect Dis 1994;19:362.
27. Martino L, Faimondi F, Scotti S, Davidson RN, Gradoni L, Giacchino R: Efficacy and tolerability of liposomal amphotericin B in Italian infants with visceral leishmaniasis. Trans R Soc Trop Med Hyg 1993; 87:477.
28. Dietze R, Milan EP, Berman JD, Grogl M, Falqueto A, Feitosa TF, Luz KG, Suassuna FAB, Marinho LAC, Ksionski G: Treatment of Brazilian kala-azar with a short course of Amphocil (Amphotericin B Cholesterol Dispersion). Clin Infect Dis 1993;17:981-986.
29. Dietze R, Fagundes SMS, Brito EF, Milan EP, Feitosa TF, Suassuna FAB: Treatment of Brazilian kalaazar with Amphocil (ABCD) for 5 days. Trans R Soc Trop Med Hyg 1995;89:309-11.